MENU
+Compare
RPTX
Stock ticker: NASDAQ
AS OF
Apr 2 closing price
Price
$1.07
Change
+$0.05 (+4.90%)
Capitalization
45.49M

RPTX Repare Therapeutics Forecast, Technical & Fundamental Analysis

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer... Show more

RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RPTX with price predictions
Apr 02, 2025

Momentum Indicator for RPTX turns negative, indicating new downward trend

RPTX saw its Momentum Indicator move below the 0 level on February 28, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned negative. In of the 94 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RPTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RPTX entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RPTX's RSI Indicator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for RPTX just turned positive on April 02, 2025. Looking at past instances where RPTX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RPTX advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .

RPTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.301) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.849) is also within normal values, averaging (252.036).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RPTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RPTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RPTX is expected to report earnings to fall 6.34% to -62 cents per share on May 13

Repare Therapeutics RPTX Stock Earnings Reports
Q1'25
Est.
$-0.63
Q4'24
Beat
by $0.14
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.28
The last earnings report on March 03 showed earnings per share of -67 cents, beating the estimate of -81 cents. With 312.08K shares outstanding, the current market capitalization sits at 45.49M.
A.I. Advisor
published General Information

General Information

a company which engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7210 Frederick-Banting Street
Phone
+1 857 412-7018
Employees
179
Web
https://www.reparerx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDYA16.351.58
+10.70%
IDEAYA Biosciences
MRSN0.340.01
+1.68%
Mersana Therapeutics
FRBA14.860.11
+0.75%
First Bank
FCX38.200.07
+0.18%
Freeport-McMoran
CIG1.72N/A
N/A
Companhia Energetica De Minas Gerais-CEMIG

RPTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
+4.90%
INO - RPTX
57%
Loosely correlated
+10.67%
BCYC - RPTX
48%
Loosely correlated
+2.55%
ALNY - RPTX
38%
Loosely correlated
+4.33%
AXON - RPTX
37%
Loosely correlated
+3.18%
GSGTF - RPTX
34%
Loosely correlated
N/A
More